Blood Culture Test Market Expected to Reach $8.186 Billion by 2027

Blood culture test market was valued at $3.900 billion in 2019, and is projected to reach $8.186 billion by 2027, registering a CAGR of 9.3% from 2020 to 2027. The blood culture test is a procedure used to detect the presence of microorganism such as fungi or bacteria in the blood. It diagnosis the causative agent responsible for bloodstream infection and provides a better therapeutic approach. The blood culture test is often done in conjunction with other diagnostic tests such as chemical analysis and complete blood count. The blood culture test helps to determine the infection and provides appropriate treatment required for a patient.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
T2 BIOSYSTEMS, INC., F. HOFFMANN-LA ROCHE LTD, THERMO FISHER SCIENTIFIC, INC., BIOMÉRIEUX SA, AUTOBIO DIAGNOSTICS CO. LTD, LUMINEX CORPORATION, OPGEN INC., BRUKER CORPORATION, NEOGEN Corporation (Abtek Biologicals), BECTON, DICKINSON AND COMPANY

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/11479

Repeated demand for blood culture from patients suffering from COVID-19 to determine the prevalence of bacterial has a positive impact on the blood culture test market. As per the data published in the National Library of Medicine, in 2020, the ordering volume for blood culture tests increased by 34.8% in the second half of March 2020 as compared to first half of March.

As per the data published by the United Nations Children Fund (UNICEF) in 2021, around 1,400 cases of pneumonia per 100,000 children were diagnosed, every year and one child die due to pneumococcal infection (bacteremia and pneumonia) for every 39 seconds. With the help of blood culture tests, these diseases can easily be diagnosed, controlled, and prevented from becoming severe in nature. The diagnostic devices for blood culture test are recently emerging technologies that are gaining acceptance and are being adopted by various healthcare professionals. Furthermore, the use of polymers chain reaction (PCR), microarray, and peptide nucleic acid-fluorescent in situ hybridization (PNA-FISH) are increasing due to their higher accuracy, high specificity in tests, and lower lead time. Thus, the rise in prevalence of bacterial infection and advancements in diagnostic techniques in blood culture test support the market growth.

The global blood culture test market is segmented into product, method, application and region. On the basis of product, the market is divided into consumables, instruments, and software & services. The consumable segment dominated the market in 2019, as the demand for use of consumables is rising, owing to increase in application of blood culture media as well as assay, kits, and reagent.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/11479

Depending on method, the blood culture test market is categorized into conventional and automated blood culture method. The conventional segments spearheaded the market in 2019, owing to its extensive use of conventional blood culture methods in independent clinical laboratories, hospitals, and pathology laboratories. The applications covered in the study include bacterial, fungal, and others. The bacterial segment led the market in 2019, and is expected to continue this trend throughout the forecast period, as the bacterial infection is the leading cause of bloodstream infection and sepsis.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.